Bio-Connect

MAPK14 (phospho-Tyr323) antibody

Research Use Only
ORB7090
Biorbyt
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityCanine, Chicken, Equine, Human, Mouse, Porcine, Rabbit, Rat
TargetMAPK14
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Biorbyt
  • Product Name
    MAPK14 (phospho-Tyr323) antibody
  • Delivery Days Customer
    16
  • Applications
    Flow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB=1:500-2000, IHC-P=1:100-500, Flow-Cyt=2ug/Test, IHC-F=1:100-500, IF=1:100-500, ELISA=1:5000-10000 ELISA, FC, IF, IHC-Fr, IHC-P, WB
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID1432
  • Target name
    MAPK14
  • Target description
    mitogen-activated protein kinase 14
  • Target synonyms
    CSAID-binding protein; CSBP; CSBP1; CSBP2; CSPB1; cytokine suppressive anti-inflammatory drug binding protein; EXIP; MAP kinase 14; MAP kinase Mxi2; MAP kinase p38 alpha; MAX-interacting protein 2; mitogen-activated protein kinase 14; mitogen-activated protein kinase p38 alpha; Mxi2; p38; p38 MAP kinase; p38 mitogen activated protein kinase; p38ALPHA; p38alpha Exip; PRKM14; PRKM15; RK; SAPK2A; stress-activated protein kinase 2A
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ16539
  • Protein Name
    Mitogen-activated protein kinase 14
  • Scientific Description
    MAPK14 (phospho-Tyr323) antibody
  • Reactivity
    Canine, Chicken, Equine, Human, Mouse, Porcine, Rabbit, Rat
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension. Zhao H et al., 2017 Jan, Int Immunopharmacol
    Read more